Basal insulin glargine vs prandial insulin lispro in type 2 diabetes

Lancet. 2008 Aug 2;372(9636):371-2; author reply 372. doi: 10.1016/S0140-6736(08)61153-8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dose-Response Relationship, Drug
  • Fasting / blood
  • Humans
  • Hypoglycemia / chemically induced
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / administration & dosage
  • Insulin / adverse effects
  • Insulin / analogs & derivatives*
  • Insulin / therapeutic use
  • Insulin Glargine
  • Insulin Lispro
  • Insulin, Long-Acting

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin Lispro
  • Insulin, Long-Acting
  • Insulin Glargine